In conclusion, the current findings uncover an unconventional pharmacological role of STING agonists in the alleviation of opioid-induced itch and dermatitis-induced chronic itch by regulating spinal TBK1-IRF3-dependent IFN-I response, ERK phosphorylation and subsequent cerebral functional connectivity in mice. This evidence concerns the gene TBK1 and skin disorder.